Luteal Phase Insufficiency

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Luteal Phase Insufficiency trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 1

NCT07136922

First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency

The aim of this clinical trial is to assess safety of a new vaginal 400mg progesterone drug-device combination product in a first in human trial. Additionally,…

United Kingdom20 participantsStarted 2026-04

Treatment: 400mg progesterone Callavid - 2hr wear, Cyclogest 400 mg

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT07028710

Early Luteal Phase Progesterone Kinetics After hCG-Induced Ovulation in Modified Natural Cycle

This pilot study evaluates how progesterone levels change after hCG-triggered ovulation in modified natural cycles. Forty women preparing for frozen embryo tran…

Location not specified40 participantsStarted 2026-01-15

Treatment: hCG

UnknownNot Applicable

NCT03480412

Second Step Protocol in Poor Ovarian Responder (POR)

Reduced ovarian reserve and the consequent poor ovarian response are very recurent in infertile patients, indeed a percentage of 10%-24% of couples addressed to…

Italy50 participantsStarted 2017-09-01

Treatment: Follicular Phase, Luteal Phase